Indegene Limited (NSE:INDGN)

India flag India · Delayed Price · Currency is INR
471.60
-8.35 (-1.74%)
At close: Mar 4, 2026
-10.84%
Market Cap 113.19B
Revenue (ttm) 32.63B
Net Income (ttm) 4.39B
Shares Out 240.01M
EPS (ttm) 18.21
PE Ratio 25.89
Forward PE 22.81
Dividend 2.00 (0.42%)
Ex-Dividend Date n/a
Volume 424,205
Average Volume 446,492
Open 470.60
Previous Close 479.95
Day's Range 460.80 - 481.65
52-Week Range 455.60 - 632.90
Beta n/a
RSI 41.23
Earnings Date Apr 28, 2026

About Indegene

Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technolo... [Read more]

Sector Healthcare
Founded 1998
Employees 4,158
Stock Exchange National Stock Exchange of India
Ticker Symbol INDGN
Full Company Profile

Financial Performance

In fiscal year 2025, Indegene's revenue was 28.39 billion, an increase of 9.64% compared to the previous year's 25.90 billion. Earnings were 4.07 billion, an increase of 20.79%.

Financial Statements

News

There is no news available yet.